Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Nicolas Jacquelot(The University of Melbourne), Cyril Seillet(The University of Melbourne), Minyu Wang(The University of Melbourne), Angela Pizzolla(The University of Melbourne), Yang Liao(The University of Melbourne), Soroor Hediyeh-zadeh(The University of Melbourne), Sharon Grisaru‐Tal(Tel Aviv University), Cynthia Louis(The University of Melbourne), Qiutong Huang(The University of Queensland), Jaring Schreuder(The University of Queensland), Fernando Souza-Fonseca-Guimarães(The University of Queensland), Carolyn A. de Graaf(The University of Melbourne), Kevin Thia(Peter MacCallum Cancer Centre), Sean Macdonald(Peter MacCallum Cancer Centre), Mary Camilleri(The University of Melbourne), Kylie Luong(The University of Melbourne), Shengbo Zhang(The University of Melbourne), Michaël Chopin(The University of Melbourne), Tristan Molden-Hauer(Peter MacCallum Cancer Centre), Stephen L. Nutt(The University of Melbourne), Viktor Umansky(German Cancer Research Center), Bogoljub Ćirić(Thomas Jefferson University), Joanna R. Groom(The University of Melbourne), Paul S. Foster(Hunter Medical Research Institute), Philip M. Hansbro(University of Technology Sydney), Andrew N. J. McKenzie(MRC Laboratory of Molecular Biology), Daniel H.D. Gray(The University of Melbourne), Andreas Behren(The University of Melbourne), Jonathan Cebon(The University of Melbourne), Éric Vivier(Centre National de la Recherche Scientifique), Ian P. Wicks(The Royal Melbourne Hospital), Joseph A. Trapani(The University of Melbourne), Ariel Munitz(Tel Aviv University), Melissa J. Davis(The University of Melbourne), Wei Shi(The University of Melbourne), Paul J. Neeson(The University of Melbourne), Gabrielle T. Belz(The University of Queensland)
Cited by 174Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis